INVO Fertility Corp (IVF) - Kewajiban jangka dawa marang modal

This daily price chart for INVO Fertility Inc (IVF) illustrates a debt-to-equity ratio of 0.13. INVO Fertility Inc (IVF) is optimizing costs by outsourcing the production of plastic components to verified third-party contractors. The business is based on the creation of automated INVOcell systems for embryo development, minimizing manual labor. Financial stability relies on steady interest in infertility therapy, which guarantees a predictable cash flow within the private healthcare sector.

Utang jangka dawa marang modal: INVO Bioscience, Inc. (IVF) kanggo 29.04.2025 - 30.10.2026

This ratio determines the dependence of long-term financing on the issuer's own resources. By analyzing the level of long-term debt load relative to equity, an investor assesses the stability of the balance sheet structure against credit risks. The ratio of liabilities exceeding one year to equity reveals the company's degree of financial leverage. For INVO Fertility Inc (IVF), this is critical when scaling INVOcell systems through partnerships with IVF clinics. Debt optimization ensures the stable development of joint affordable medicine projects.

Perusahaan pesaing

Boston Scientific Corp - Kewajiban jangka dawa marang ekuitas|Utang jangka dawa marang modal EW|RMD - Kewajiban jangka dawa marang modal|Utang jangka dawa marang modal PODD (Insulet Corporation)|ZBH - Rasio utang jangka dawa marang ekuitas|CooperCompanies - Utang jangka dawa marang modal|Rasio tanggungan utang jangka dawa marang modal Invisalign ALGN|GMED: Utang jangka dawa marang modal|TransMedics Group, Inc. (TMDX) - Utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Alphatec Holdings, Inc.|Utang jangka dawa marang ekuitas AORT|Utang jangka dawa marang modal ENOV|Rasio tanggungan utang jangka dawa marang modal Integra LifeSciences Corp|Motiva - Rasio utang jangka dawa marang ekuitas|BBNX (iLet Bionic Pancreas) - Kewajiban jangka dawa marang ekuitas|IRADIMED CORPORATION - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal embecta.com|TNDM: Utang jangka dawa marang modal|Rasio utang jangka dawa marang modal AXGN|Rasio utang jangka dawa marang ekuitas SIBN|OFIX: Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Bioventus Inc. (BVS)|Rasio utang jangka dawa marang ekuitas orthopediatrics.com KIDS|Utang jangka dawa marang modal TMCI (Treace Medical Concepts, Inc.)|Blade Air Mobility (SRTA) - Kewajiban jangka dawa marang modal|Carlsmed Corp - Utang jangka dawa marang modal|RXST (RxSight Ophthalmic) - Rasio utang jangka dawa marang modal|CLPT: Utang jangka dawa marang modal|STXS - Rasio tanggungan utang jangka dawa marang modal|STIM (Neuronetics) - Utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas Sight Sciences Inc. (SGHT)|Utang jangka dawa marang modal OBIO|Utang jangka dawa marang modal anikatherapeutics.com (ANIK)|Utang jangka dawa marang ekuitas InspireMD, Inc. NSPR|Jin Medical International Ltd. - Utang jangka dawa marang ekuitas|VANI: Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal XTNT (Xtant Medical Holdings)|NMTC: Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal Modular Medical, Inc. (MODD)|Utang jangka dawa marang ekuitas Myomo, Inc.|COCH - Tanggungan utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang ekuitas VVOS (Vivos Therapeutics, Inc.)|Utang jangka dawa marang modal enVVeno Medical Corporation (NVNO)|Utang jangka dawa marang modal SINT (Sintx Technologies, Inc.)|Rasio tanggungan utang jangka dawa marang modal Tenon Medical Inc (TNON)|LFWD - Utang jangka dawa marang ekuitas|Kewajiban jangka dawa marang ekuitas AMIX|Bone Biologics Corp (BBLG) - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang ekuitas Axonics Inc.|BIOL (Biolase, Inc.) - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal Dynatronics Corp. DYNT|Utang jangka dawa marang ekuitas Paragon 28, Inc. (FNA)|invobioscience.com - Rasio utang jangka dawa marang modal